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A B S T R A C T
To improve insight in the drivers of local HIV-1 transmission in Belgium, phylogenetic, demographic, epide-
miological and laboratory data from patients newly diagnosed between 2013 and 2015 were combined and
analyzed. Characteristics of clustered patients, paired patients and patients on isolated branches in the phylo-
genetic tree were compared. The results revealed an overall high level of clustering despite the short time frame
of sampling, with 47.6% of all patients having at least one close genetic counterpart and 36.6% belonging to a
cluster of 3 or more individuals. Compared to patients on isolated branches, patients in clusters more frequently
reported being infected in Belgium (95.1% vs. 47.6%; p < 0.001), were more frequently men having sex with
men (MSM) (77.9% vs. 42.8%; p < 0.001), of Belgian origin (68.2% vs. 32.9%; p < 0.001), male gender
(92.6% vs. 65.8%; p < 0.001), infected with subtype B or F (87.8% vs. 43.4%; p < 0.001) and diagnosed early
after infection (55.4% vs. 29.0%; p < 0.001). Strikingly, Sub-Saharan Africans (SSA), overall representing
27.1% of the population were signiﬁcantly less frequently found in clusters than on individual branches (6.0%
vs. 41.8%; p < 0.001). Of the SSA that participated in clustered transmission, 66.7% were MSM and this
contrasts sharply with the overall 12.0% of SSA reporting MSM. Transmission clusters with SSA were more
frequently non-B clusters than transmission clusters without SSA (44.4% versus 18.2%). MSM-driven clusters
with patients of mixed origin may account, at least in part, for the increasing spread of non-B subtypes to the
native MSM population, a cross-over that has been particularly successful for subtype F and CRF02_AG.
The main conclusions from this study are that clustered transmission in Belgium remains almost exclusively
MSM-driven with very limited contribution of SSA. There were no indications for local ongoing clustered
transmission of HIV-1 among SSA.
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1. Introduction
1.1. The value of phylogenetic analysis
Deﬁning the evolutionary relationship between viruses using simi-
larities in molecular sequences is a widely applied method for identi-
ﬁcation and visualization of HIV-1 transmission networks (Hassan
et al., 2017). Results of a recent study provided proof for the strength of
these phylogenetic methods by showing their capacity to identify
transmission partners even on an individual patient scale (Wertheim
et al., 2017). HIV-1 pol sequences are routinely generated for assess-
ment of baseline drug resistance and contain suﬃcient information for
the reliable identiﬁcation of transmission events (Hue et al., 2004).
They have been used in numerous nationwide phylogenetic studies
intended to better understand the dynamics of local HIV-1 transmission
(Kouyos et al., 2010; Leigh Brown et al., 2011; Lunar et al., 2015; Perez-
Parra et al., 2016; Brenner et al., 2017; Paraskevis et al., 2017;
Parczewski et al., 2017; Temereanca et al., 2017).
1.2. The HIV-1 epidemic in Belgium and Western Europe
With an estimated overall HIV prevalence of 1.7 infected persons
per 1000 inhabitants, the overall burden of HIV-1 in Belgium is low, but
the infection is highly concentrated in speciﬁc populations. Recent
surveys revealed a HIV-1 prevalence of 6.0% in men having sex with
men (MSM) (Vanden Berghe et al., 2011) and between 4.2% and 5.9%
in Sub-Saharan Africans (SSA) (Loos et al., 2017). A national HIV sur-
veillance system, with registration of all new diagnoses, is operating
since 1985. Care and the continuum of care are well ensured. Of all HIV
diagnosed patients living in Belgium in 2011, an estimated 98.2% are
linked to care (Van Beckhoven et al., 2015). In 2015, approximately
1000 (95% CI: 800–1200) individuals were newly diagnosed (Sasse
et al., 2015). For the same year the number of undiagnosed infections
was estimated at 2800 (95% CI: 2200–3500) (Marty et al., 2017). About
half of all new diagnoses in Belgium are in MSM. The HIV epidemic in
MSM displayed an exponential growth between 1999 and 2010 and has
then stabilized for some years with moderate decreases since 2014. The
infection in MSM is largely dominated by subtype B infections (Chalmet
et al., 2010). Infections in heterosexuals (HET) represent about 40% of
all new diagnoses, half of them in SSA. In this subpopulation a large
variety of non-B HIV-1 subtypes is seen (Fransen et al., 1996; Snoeck
et al., 2004; Dauwe et al., 2015). An increased entrance of these non-B
subtypes in the MSM population has been reported recently (Dauwe
et al., 2015), in line with observations in other Western European
countries (Beloukas et al., 2016; Esbjornsson et al., 2016; Ragonnet-
Cronin et al., 2016; Dennis et al., 2017; Vinken et al., 2017). In a study
covering the Nordic countries, Esbjornsson et al. also observed in-
creased mixing of MSM and HET in transmission clusters (Esbjornsson
et al., 2016). All these observations suggest potential changes in the
dynamics of the HIV-1 epidemic in Western Europe, with increasing
crossovers between nationalities and risk groups. Because of the large
migrant population in Belgium and the high HIV-1 burden in this group,
local transmission among migrants is expected. There are indeed in-
dications that a high proportion of migrants acquire their HIV infection
post migration in a European country (Loos et al., 2017; Alvarez-del
Arco et al., 2017) but there is no information available on the partici-
pation of SSA in local transmission networks.
1.3. Study objective
The aim of the present study was to deﬁne characteristics and dri-
vers of the current HIV-1 epidemic in Belgium by combining phyloge-
netic cluster analysis with demographic, epidemiological and labora-
tory data for HIV-1 infections diagnosed between 2013 and 2015.
2. Methods
2.1. Study population and data collection
HIV-1 diagnosis and care in Belgium is centralized in 11 Aids
Reference Centers and 7 Aids Reference Laboratories, established across
the country. Demographic and epidemiological data of all new diag-
noses are registered in a national HIV surveillance system. Generalized
baseline drug resistance testing of all newly diagnosed, therapy naïve,
individuals is operational since 2005.
For the period covered by this study (2013 to 2015), baseline HIV-1
pol sequences were available for about 60% of all newly diagnosed
persons. The most important reason for missing baseline sequence data
is not being therapy naive at the time of ﬁrst diagnosis in Belgium. All
baseline pol sequences generated for therapy naive patients diagnosed
between 2013 and 2015 were used. Demographic and epidemiological
data included gender, age at diagnosis, country of birth, transmission
route and country of infection. Transmission risk categories were MSM,
HET, intravenous drug users (IVDU), blood transfusion and perinatal
infection. Because of the small numbers of IVDU (n=14), blood
transfusion (n=12) or perinatal infection (n=9) these categories
were excluded for statistical analysis but the two patients being MSM
and IVDU were classiﬁed in the MSM category because in the phylo-
genetic tree, both were closely linked with individuals infected through
MSM. For the category “country of birth”, patients were classiﬁed as
Belgian, European (born in any European country except Belgium), SSA
or “other”. For the country of infection we focused on infections in
Belgium and infections in Sub-Saharan Africa. Patients reporting in-
fection outside of these countries were grouped as “other”. Viral load,
CD4+ T cell count and pol gene sequence data were obtained from the 7
Belgian Aids Reference Laboratories. Collection of sequence data was
facilitated by the use of a network database (Integrated Database
Network System, Smartgene, Zug, Switzerland).
2.2. Sequencing
Partial Pol sequences were generated in one of the 7 Aids Reference
Laboratories using population sequencing and either an in-house pro-
tocol or the TruGene HIV-1 genotyping kit (TruGene, Siemens
Healthcare Diagnostics GmbH, Eschborn, Germany). The length of the
generated sequences slightly diﬀered according to the sequencing
protocol. Therefore, only the 870 nucleotides, representing codons 9 to
99 of the protease gene and codons 41 to 239 of the reverse transcriptase
gene and covered by all methods, were included in the alignment.
Alignments were composed in BioEdit (http://www.mbio.ncsu.edu/
BioEdit/bioedit.html). Gaps resulting from the insertions of three nu-
cleotides at codon positions 33 or 35 of the protease gene, observed in 8
of the 1665 sequences, were removed. Positions associated with drug
resistance were kept after excluding any inﬂuence on the tree topology
or cluster identiﬁcation.
2.3. Phylogenetic analysis and cluster identiﬁcation
A phylogenetic tree was reconstructed using the maximum like-
lihood (ML) approach implemented in PhyML 3.0 (Guindon et al.,
2010) with automatic selection of the best ﬁt evolutionary model of
DNA substitution (GTR+G+ I) using the Akaike information criterion
(AIC). Branch support was obtained by approximate likelihood-ratio
test (aLRT, SH-like) (Anisimova and Gascuel, 2006), a likelihood based
alternative to the computationally intensive bootstrapping. Sequences
clustering with at least one other sequence with aLRT of ≥0.97 and a
mean pairwise distance ≤0.015 were considered as genetically linked.
After deﬁning the clusters, all sequences with a distance of> 0.030 to
the closest relative were removed as cluster members and considered as
individual branched patients. A radial cladogram was drawn using the
Interactive Tree of Life web service at http://itol.embl.de/ (Letunic and
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Bork, 2011).
2.4. Subtyping and identiﬁcation of transmitted drug resistance mutations
(TDRM)
HIV-1 subtyping was performed using the COMET HIV-1 (Version
1.0) (Struck et al., 2014) and Rega v3.0 genotyping tools (Pineda-Pena
et al., 2013). The subtype was attributed in case of a concordant result
for both tools and considered as “undeﬁned” in all other cases. Trans-
mitted drug resistance mutations were identiﬁed using the World
Health Organization (WHO) 2009 surveillance list (Bennett et al., 2009)
with additional inclusion of the E138K mutation, a mutation that in-
duces resistance against a non-nucleoside reverse transcriptase in-
hibitor that became available after 2009.
2.5. Infection timing
The recency of infection at diagnosis was estimated using the BED
HIV-1 Incidence EIA and the HIV-1 LAg-Avidity EIA (both from Sedia
Biosciences Corporation, Portland, Oregon, USA). These methods have
been extensively validated. A concordant prediction of recent infection
in both assays was shown to be a reliable predictor for an infection
acquired<4months before (Verhofstede et al., 2017). For practical
reasons infection timing was limited to patients newly diagnosed in
2014.
2.6. Statistical analysis
Univariate analyses were performed using Pearson Chi-Square for
categorical variables and Mann-Whitney U nonparametric test for
continuous variables. Variables with a p-value≤ 0.05 in the univariate
analysis were included in the multivariate analysis. If considered ap-
propriate, the categories for a variable were restricted, e.g. by omission
of the “other” category, or grouped e.g. for subtype B and F infections.
For certain variables (country of birth, CD4 count and viral load) it was
assumed that the lack of data for part of the patients was random and a
multiple imputation model was used to complete missing data before
proceeding to multivariate analysis. Fifty imputed data sets were cre-
ated and multivariate analysis was run on the pooled dataset. Binary
logistic regression was performed using backward selection and a sig-
niﬁcance level of 0.05. Bonferroni adjustment was applied to correct for
multiple testing. All data were analyzed using SPSS (IBM SPSS Statistics
for Windows, Version 23.0. Released 2015; IBM Corp, Armonk, NY,
USA).
Fig. 1. ML phylogenetic tree of 1665 patients newly diagnosed in Belgium between 2013 and 2015. Tree branches colored according to subtype. The tree scale refers to the number of
nucleotide substitutions per site.
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2.7. GenBank accession numbers
Sequences of one representative of each of the 84 clusters have been
deposited into GenBank (accession numbers MG897604-MG897687).
All other sequences are available on request.
2.8. Ethics statements
The study was approved by the ethical boards of the participating
institutions with the Ethical Committee of Ghent University Hospital
operating as the central organization (reference number 2014/0717).
Apart from the incidence analyses, performed on rest material, all
analyses were performed with existing data. Anonymized patient
identiﬁers were used to combine baseline sequences, incidence, de-
mographic and behavior data.
3. Results
3.1. Study population
The study population comprised 1665 individuals, 658 diagnosed in
2013, 557 in 2014 and 450 in 2015. Mean age at diagnosis was 38 years
(IQR 29–45), 76.8% of the patients were male. Mean viral load and CD4
count were 4.80 log c/ml (IQR 4.26–5.38) and 428 cells/mm3 (IQR
234–575) respectively. Of the 1290 patients with registered country of
birth, 47.9% were Belgians and 27.1% SSA. Of the 1395 patients with
registered transmission risk, 56.9% were MSM and 40.5% HET. The
HIV-1 subtype distribution for the 1631 patients with attributed sub-
type was 53.1% B, 16.2% CRF02_AG, 8.6% F, 8.4% A, 5.2% C, 2.6%
CRF01_AE and 5.9% other subtypes or CRF. Overall, 164 patients
(9.9%) were infected with a variant containing at least one transmitted
drug resistance mutation. The contribution of TDRM against non-nu-
cleoside reverse transcriptase, nucleoside reverse transcriptase and
protease inhibitors was respectively 51.3%, 36.0% and 12.7%. The
phylogenetic tree colored according to subtype distribution is shown in
Fig. 1.
3.2. Phylogenetic analysis
Phylogenetic analysis revealed at least one close genetic counterpart
for 793 (47.6%) of the 1665 patients while 872 (52.4%) resided on
isolated branches in the tree. Of the 793 patients with a close genetic
counterpart, 186 (23.6%) were linked with a single other individual,
resulting in the formation of 93 pairs, and 607 (76.5%) were members
of a transmission cluster of 3 or more individuals. Overall, 84 trans-
mission clusters of 3 or more individuals were identiﬁed. These clusters
comprised 36.5% of all patients.
3.3. Characteristics of patients in transmission clusters
The comparison between patients in clusters of 3 or more and pa-
tients on isolated branches is shown in Table 1. This comparison
highlights the pronounced involvement of individuals infected in Bel-
gium (95.1%), MSM (77.9%) and native Belgians (68.2%) in clustered
transmission. Other characteristics signiﬁcantly associated with clus-
tering were male gender, subtype B or F infection, high CD4 count at
diagnosis, high viral load at diagnosis and being diagnosed early after
infection. For multivariate analyses (Table 2), the comparison was re-
stricted to Belgians and SSA for the variables “country of birth” and
“country of infection” and to subtype B or F versus the other subtypes
for the variable “subtype”. Male gender, Belgian origin, being infected
with a subtype B or F virus, younger age, higher viral load and higher
CD4 count were all identiﬁed as independent predictors for being
member of a transmission cluster. Transmission risk and presence of
TDRM were not withhold as independent predictors in multivariate
analysis.
Of the 607 individuals in transmission clusters, 419 were subtype B
infections (64 clusters), followed by subtype F (114 individuals, 4
clusters), CRF02_AG (48 individuals, 10 clusters), subtype A (16 in-
dividuals, 3 clusters), C (6 individuals, 2 clusters) and “other” (4 in-
dividuals, 1 cluster).
Drug resistance mutations were found in 76 clustered patients
(12.5%). In the majority of them (83.9%) only one resistance mutation
was detected. Nucleoside reverse transcriptase inhibitor revertant mu-
tations at position 215 (T215E/D; 4 clusters, 35 patients) and the non-
nucleoside reverse transcriptase inhibitor mutation K103N (2 clusters,
16 patients) were the most represented. Multiclass resistance was found
in two clusters, with a combination of the protease mutations I54V and
N88D and nucleoside reverse transcriptase mutations L210W and
T215S in one cluster (7 patients) and a combination of the nucleoside
reverse transcriptase revertant mutation T215D and the non-nucleoside
reverse transcriptase mutation Y181C in another cluster (3 patients).
Twenty-six of the 84 transmission clusters had 7 or more members
Table 1
Results of univariate analysis for comparison between patients on isolated branches in the
phylogenetic tree and patients in phylogenetic clusters of ≥3. For each parameter only
the patients with available information for that parameter were included. Pearson Chi-
Square test was used for categorical variables and Mann-Whitney U nonparametric test
for continuous variables.
All Position in phylogenetic tree p-Value
Isolated
branch
Clustered≥ 3
N=1479 N=872 N=607
Gender (n= 1479), n (%)
Male 1136 (76.8) 574 (65.8) 562 (92.6) <0.001
Female 343 (23.2) 298 (34.2) 45 (7.4)
Age at diagnosis
(n= 1479),
mean (IQR)
38 (29–45) 38 (30–46) 37 (28–44) 0.005
Transmission risk (n= 1206), n (%)
MSM 698 (57.9) 295 (42.8) 403 (77.9) <0.001
HET 508 (42.1) 394 (57.2) 114 (22.1)
Country of birth (n=1139), n (%)
Belgium 535 (47.0) 226 (32.9) 309 (68.2) <0.001
Europe 145 (12.7) 74 (10.8) 71 (15.7)
Sub-Saharan
Africa
314 (27.6) 287 (41.8) 27 (6.0)
Other 145 (12.8) 99 (14.5) 46 (10.1)
Country of infection (n=880), n (%)
Belgium 613 (69.7) 224 (47.6) 389 (95.1) <0.001
Sub-Saharan
Africa
154 (17.5) 150 (31.8) 4 (1.0)
Other 113 (12.8) 97 (20.6) 16 (3.9)
Subtype (n= 1451), n (%)
B 762 (52.5) 343 (40.6) 419 (69.0) <0.001
F 138 (9.5) 24 (2.8) 114 (18.8)
02_AG 237 (16.3) 189 (22.4) 48 (7.9)
A 115 (7.9) 99 (11.7) 16 (2.6)
C 74 (5.1) 68 (8.1) 6 (1.0)
01_AE 34 (2.3) 34 (4.0) 0 (0)
Other 91 (6.3) 87 (10.3) 4 (0.7)
CD4+ T cells
(cells/mm3)
(n= 1024),
mean (IQR)
428
(234–575)
376
(188–516)
487 (317–624) <0.001
Viral load (log
copies/ml)
(n= 1430),
mean (IQR)
4.80
(4.26–5.38)
4.73
(4.20–5.33)
4.93 (4.41–5.49) <0.001
Infection stage at diagnosis (n= 456), n (%)
Early 179 (39.3) 81 (29.0) 98 (55.4) <0.001
Late 277 (60.7) 198 (71.0) 79 (44.6)
Transmitted drug resistance (n= 1479), n (%)
Yes 157 (10.6) 81 (9.3) 76 (12.5) 0.047
No 1322 (89.4) 791 (90.7) 531 (87.5)
n: number; IQR: Interquartile Range; MSM: men having sex with men, HET: heterosexual.
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and were considered as large clusters with presumed high impact on
ongoing local transmission. The characteristics of these 26 large clusters
are represented in Table 3. Nineteen (73.1%) had only Belgian mem-
bers and 16 (61.5%) were men-only. With regard to the transmission
risk, 8 (30.8%) were MSM-only and 18 were mixed MSM and HET. Of
these 18 mixed transmission risk clusters however, 8 were men only.
The overall gender ratio was 344 men over 32 women. The 32 women
were distributed over 10 clusters including a large women-dominated
cluster (cluster 1410; 10 females, 1 male), 3 clusters with at least one
quarter of female members and 4 clusters with a lower female con-
tribution (Table 3).
3.4. Contribution of SSA in transmission clusters
Twenty seven (7.7%) of the 350 SSA were member of a transmission
cluster. They were distributed over 18 clusters of which 13 with only a
single Sub-Saharan African member (Table 4). Nine of the 18 clusters
with SSA (50.0%) were mixed risk clusters, 6 (33.3%) were MSM only
and 3 (16.7%) were HET only. In line, the majority of SSA in clusters
(18/27; 66.7%) were MSM versus 8/27 (29.6%) HET and 1/27 (3.7%)
unknown or other risk. This contrasts sharply with the overall risk
distribution for the SSA in the study with 78.3% HET, 12.0% MSM and
9.7% other or unknown risk. About half (55.6%) of clusters with at least
one SSA member were subtype B clusters, 6 (33.3%) were CRF02_AG
and 2 (11.1%) were subtype F infections. For comparison, of the 66
clusters without SSA members, 54 (81.8%) were subtype B and 12
(18.2%) were non-B clusters.
3.5. Characteristics of paired patients
Signiﬁcant diﬀerences were observed between patients in pairs and
patients in transmission clusters. Paired patients were more frequent
females (23.1% versus 7.4%; p < 0.001), HET (35.6% vs. 21.8%;
p < 0.001), of SSA origin (23.8% vs. 6.0%; p < 0.001), infected in
Sub-Saharan Africa (13.7% vs. 0.5%; p < 0.001) and infected with a
non-B virus (42.2% vs. 31.0%; p < 0.001) compared to the patients in
transmission clusters. The TDRM prevalence in paired patients was
lower than the TDRM prevalence in clustered patients (4.3% vs. 12.5%;
p < 0.001).
Signiﬁcant diﬀerences were also observed between patients in pairs
and patients on single branches. Compared to the isolated patients,
pairs were more frequently males (76.9% vs. 65.8%; p= 0.003), MSM
(59.4% vs. 41.4%; p < 0.001), of Belgian origin (55.0% vs. 32.9%;
p < 0.001), infected in Belgium (76.1% vs. 47.4%; p < 0.001) and
infected with a subtype B virus (57.8% vs. 40.6%; p < 0.001). TDRM
prevalence was lower in pairs (4.3% vs. 9.3%; p= 0.026).
Table 2
Model of independent risk factors associated with phylogenetic clustering based on
multivariate logistic regression analysis with Bonferroni adjustment. All variables with a
p-value≤ 0.05 in the univariate analysis were retrieved for multivariate analysis. A
multiple imputation model was used to adjust for missing data. For subtype and country
of birth the categories were limited to the most informative.
Risk factors Multivariate analysis
OR p value 95% conﬁdence interval
Gender
Male 2.078 <0.001 1.385–3.118
Female 1 – Ref
Age at diagnosis 0.972 <0.001 0.960–0.984
CD4+ T cells 1.001 <0.001 1.001–1.002
Viral load 1.475 <0.001 1.255–1.733
Subtype
B or F 4.559 <0.001 3.190–6.515
Other 1 – Ref
Country of birth
Belgium 2.808 <0.001 1.781–4.426
Sub-Saharan Africa 1 – Ref
OR: Odds Ratio; Ref: reference category.
Table 3
Patient composition for the 26 large transmission clusters (≥7 members).
Cluster ID N Gender (n) Transmission risk (n) Country of birth (n) Country of infection (n) Subtype
Male Female MSM HET U/O Belgium Sub-Saharan Africa U/O Belgium Other U/O
1304 94 90 4 68 15 11 64 1 29 70 3 21 F
1313 32 31 1 25 3 4 15 0 17 19 1 12 B
1443 30 28 2 20 7 3 23 1 6 19 0 11 B
1340 24 24 0 16 0 8 9 0 15 13 0 11 B
1449 14 10 4 7 5 2 4 1 9 10 1 3 B
1307 14 12 2 8 3 3 8 0 6 10 0 4 B
1306 12 12 0 8 4 0 11 0 1 10 2 0 B
1410 11 1 10 0 11 0 8 1 2 9 0 2 F
1354 10 10 0 9 0 1 3 0 7 8 0 2 B
1434 10 10 0 5 2 3 3 0 7 3 1 6 B
1357 10 9 1 3 6 1 5 0 5 7 0 3 B
1447 9 9 0 8 0 1 2 0 7 7 1 1 B
1309 9 9 0 7 1 1 6 0 3 7 0 2 B
1346 9 9 0 8 1 0 5 0 4 6 0 3 B
1414 9 9 0 8 0 1 1 0 8 5 1 3 02_AG
1456 8 7 1 6 1 1 1 1 6 1 1 6 B
1303 8 3 5 0 6 2 5 1 2 3 0 5 02_AG
1424 7 7 0 4 1 2 0 5 2 3 0 4 B
1341 7 7 0 5 2 0 3 0 4 4 0 3 B
1310 7 7 0 6 0 1 5 0 2 4 0 3 B
1311 7 7 0 5 0 2 5 0 2 5 0 2 B
1334 7 7 0 4 1 2 5 0 2 4 0 3 B
1342 7 7 0 5 0 2 4 0 3 5 0 2 B
1364 7 7 0 5 0 2 2 0 5 3 0 4 B
1403 7 5 2 4 3 0 4 0 3 5 1 1 A
1438 7 7 0 4 1 2 2 0 5 5 0 2 B
N: total number; n: number; MSM: men having sex with men; HET: heterosexual; U/O: unknown/other.
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3.6. Characteristics of patients on isolated branches in the phylogenetic tree
Compared to the genetically linked patients, patients on individual
branches were more frequently female (34.2% vs. 11.1%; p < 0.001),
HET (55.3% vs. 25.1%; p < 0.001), SSA (41.8% vs. 10.4%;
p < 0.001), infected outside of Belgium (52.4% vs. 9.2%; p < 0.001)
and infected with a non-B subtype (59.4% vs. 33.5%; p < 0.001). They
had a lower CD4 count (mean 376 cells/mm3, IQR 188–516 vs. mean
485 cells/mm3, IQR 300–630; p < 0.001) and were less frequently
diagnosed early after infection (29.0% of the 279 patients with in-
formation on the infection time vs. 53.5% of the 245 patients with
known infection time; p < 0.001). Although a signiﬁcant lower
number of patients on individual branches reported infection in
Belgium still 47.6% acquired the infection locally and a high number of
these individuals were of Belgian origin (32.9%) and/or MSM (42.8%).
4. Discussion
4.1. General ﬁndings
With this nationwide viral phylodynamics study we aimed to
broaden our insight on the HIV-1 epidemic in Belgium. The study
comprised 1665 HIV-1 infected individuals newly diagnosed between
2013 and 2015, representing at least 60.0% of all patients diagnosed in
Belgium during that period. Results from phylogenetic analysis were
combined with demographic, epidemiological and laboratory data.
Despite the short time frame of sample collection we found that 47.6%
of the 1665 patients were genetically linked to at least one other in-
dividual and 36.5% were member of a transmission cluster. The pro-
portion of patients contributing to transmission clusters closely ap-
proaches the 33.4% recorded in 2010 in a study that covered only a
small part of the country (Chalmet et al., 2010). Comparable high fre-
quencies of transmission clustering have been reported for other
countries where the HIV epidemic is primarily MSM driven (Bezemer
et al., 2010; Brenner et al., 2011; Chan et al., 2015; Brenner et al., 2017;
Patino-Galindo et al., 2017). The results of our study conﬁrmed the
high contribution of MSM in clustered transmission. Importantly, de-
spite the presence of large populations of SSA in the country, SSA were
rarely observed in HIV-1 transmission clusters.
4.2. Transmitted drug resistance
The overall prevalence of baseline drug resistance was 9.9%, a
ﬁgure that is comparable with the results of previous national surveys
(Muyldermans and Sasse, 2014). There was no diﬀerence in prevalence
of drug resistance between clustered patients and patients on individual
branches. Also in line with previous reports, the non-nucleoside reverse
transcriptase inhibitor mutation K103N and nucleoside reverse tran-
scriptase inhibitor revertant mutations at position 215 (T215S/E/D)
were the most frequently present in transmission clusters (Ruelle et al.,
2013; Pineda-Pena et al., 2014). Moreover, a phylogenetic link between
our cluster 1449 and a Belgian transmission cluster with K103N de-
scribed by Ruelle et al. in 2013 and between our cluster 1334 and a
cluster with multi-drug resistance described by Pineda-Pena et al. in
2014, was evidenced (results not shown) (Ruelle et al., 2013; Pineda-
Pena et al., 2014). These ﬁndings illustrate the long term persistence
and continuing expansion of transmission clusters.
4.3. Cluster identiﬁcation and characteristics of patients involved in
clustered transmission
Selection of appropriate criteria for the identiﬁcation of transmis-
sion clusters is complex and largely depends on the research question
asked (Hassan et al., 2017). Because the aim of this study was to
characterize the drivers of local transmission, highly stringent cluster
identiﬁcation criteria were applied in order to increase the chance of
targeting clusters resulting from local transmission events. The ob-
servation that 90.0% of the patients with a genetic link and 95.1% of
the patients in transmission clusters report being infected in Belgium
supports the relevance of the chosen strategy.
In analogy with other Western European countries (Kouyos et al.,
2010; Leigh Brown et al., 2011; Abecasis et al., 2013; Audelin et al.,
2013; Frentz et al., 2013; Esbjornsson et al., 2016; Perez-Parra et al.,
2016; Parczewski et al., 2017), the clustered HIV-1 transmission in
Belgium remains predominantly MSM driven. The vast majority of
cluster members (68.2%) were born in Belgium with a small con-
tribution of individuals from other European countries (15.7%). Be-
cause of the large population of SSA in Belgium and the high HIV-1
burden in these migrants (Loos et al., 2017), local spread of HIV-1
within the African communities has been anticipated. No evidence
however was found to support this assumption. Of the 350 SSA
Table 4
Patient composition for the 18 clusters with at least one Sub-Saharan African representative.
Cluster ID N Gender (n) Transmission risk (n) Country of birth (n) Country of infection (n) Subtype
Male Female MSM HET U/O Belgium Sub-Saharan Africa U/O Belgium Other U/O
1424 7 7 0 4 1 2 0 5 2 3 0 4 B
1325 3 3 0 3 0 0 0 2 1 2 1 0 02_AG
1439 6 6 0 5 0 1 1 3 2 4 0 2 B
1304 94 90 4 68 15 11 64 2 28 70 3 21 F
1521 3 2 1 1 2 0 0 2 1 0 1 2 02_AG
1456 8 7 1 6 1 1 1 1 6 1 1 6 B
1302 3 1 2 0 3 0 2 1 0 2 1 0 02_AG
1303 8 3 5 0 6 2 5 1 2 3 0 5 02_AG
1328 3 3 0 3 0 0 0 1 2 0 0 3 02_AG
1410 11 1 10 0 11 0 8 1 2 9 0 2 F
1449 14 10 4 7 5 2 4 1 9 10 1 3 B
1540 3 3 0 2 1 0 0 1 2 1 0 2 B
1327 6 6 0 5 0 1 3 1 2 5 0 1 02_AG
1340 24 24 0 16 0 8 9 1 14 13 0 11 B
1417 5 5 0 4 1 0 2 1 2 2 0 2 B
1432 4 4 0 4 0 0 1 1 2 2 2 0 B
1436 5 5 0 4 1 0 3 1 1 5 0 0 B
1443 30 28 2 20 7 3 23 1 6 19 0 11 B
Clusters are ordered according to the contribution of Sub-Saharan African members (numbers in bold)
N: total number; n: number; MSM: men having sex with men; HET: heterosexual; U/O: unknown/other.
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included, only 7.7% were member of a cluster. These SSA were divided
over multiple clusters, many of them with a majority of native Belgians.
Strikingly, the majority of SSA in clusters were MSM (66.7%). No evi-
dence was found for the clustered heterosexual transmission among
SSA. Some potential bias must however be considered. The migrant
population is slower to engage in care than the native population (Van
Beckhoven et al., 2015) and more likely to have undiagnosed infection
(Loos et al., 2017; Marty L., 2017) so it may be that the selection of SSA
is not fully representative. It is also possible that clustered transmission
among SSA occurs but to a low extent, which will hamper its detection
when analyzing samples collected during a relatively short time frame.
In that sense, it is important to consider the higher contribution of SSA
in phylogenetic pairs. We found indications that at least part of these
paired transmissions took place in Belgium (results not shown). Another
factor that needs to be taken into account is that the per-contact
probability of HIV transmission in heterosexuals is lower than in
homosexuals. This will reduce the chance for expansion of heterosexual
transmission clusters (Patel et al., 2014).
4.4. Observation of mixed transmission risk clusters
The observation of clusters with a mixture of MSM and HET has
been reported before (Kouyos et al., 2010; Ruelle et al., 2013; Hue
et al., 2014) but recently, Esbjörnsson et al. found increased mixing of
MSM and HET in clustered transmission in the Nordic Countries
(Esbjornsson et al., 2016). We also observed a signiﬁcant number of
mixed clusters but noticed that in the majority of them the number of
MSM clearly outweighed the number of HET and in many only men
were represented. This observation suggests that misreporting of
transmission risk may be an important reason for the presence of mixed
clusters. Hue et al. calculated that in the UK at least 6.0% of the male
HET with subtype B infection were in fact incorrectly reported MSM
infections (Hue et al., 2014). The most important reason for mis-
reporting was fear or embarrassment to disclose sex with other men. In
line with this hypothesis is the more recent observation of under-
reported male-to-male sex in Dutch and Flemish HIV-1 infected donors
(van de Laar et al., 2017). Another explanation for the presence of
mixed transmission risk clusters may be the involvement of bi-sexual
individuals, as was demonstrated for the epidemic in Greenland (Bruhn
et al., 2014). Along the same line, IVDU may serve as go-between risk
categories.
4.5. Cross over of non-B subtypes to the native population
Cross over of non-B subtypes to the native population has been
documented in several Western European countries (von Wyl et al.,
2011; Brand et al., 2012; Chaix et al., 2013; Dauwe et al., 2015; Fabeni
et al., 2015; Ragonnet-Cronin et al., 2016) and increasing trends of non-
B infections have been reported (Neogi et al., 2014). These observations
fuel the idea of increased involvement of migrants in local transmission.
In our population especially clustered transmission of subtype F but also
CRF02_AG was observed. The recent introduction and fast spread of
subtype F, especially among MSM, was also seen in Italy (Lai et al.,
2014; Lai et al., 2010), Spain (Thomson et al., 2012; Delgado et al.,
2015; Paraskevis et al., 2015), Switzerland (Castro et al., 2010) and
France (Frange et al., 2012). Supplementary phylogenetic analyses of
the subtype F variants detected in our population revealed a genetic
link with Brazilian (Op De Coul et al., 2000) and Romanian (Gao et al.,
1998; Sanabani et al., 2006) strains (data not shown). A South Amer-
ican origin has been established before for subtype F variants found in
Italy (Lai et al., 2014), Spain (Delgado et al., 2015) and Belgium
(Vinken et al., 2017). Cross over of CRF02_AG to native MSM was ob-
served in Italy (Giuliani et al., 2013), Sweden (Esbjornsson et al., 2016)
and France (Chaillon et al., 2017). Why the introduction of subtype F
and CRF02_AG has been so successful in our Belgian population is not
clear but it is likely due to chance and availability. Due to the high
number of migrants from Central and Western Africa, CRF02_AG is
overall the most frequently detected non-B subtype in the country.
CRF02_AG was, next to subtype B, the most represented subtype in
clusters with at least one member born in Sub-Saharan Africa and
clusters with mixed patient origin probably constitute the most im-
portant source of non-B subtype introduction in the native population.
In the UK, where subtype C accounted for 34.3% of all infections be-
tween 2002 and 2010 (UK Collaborative Group on HIV Drug Resistance,
2014), cross over of subtype C to the native MSM was most frequently
observed (Ragonnet-Cronin et al., 2016) and in Greece, where subtype
A accounted for 51.3% of the infections between 2006 and 2012
(Davanos et al., 2015), clustered MSM transmission of mainly subtype A
has been reported (Antoniadou et al., 2014).
4.6. Characteristics of patients on isolated branches in the phylogenetic tree
While most phylogenetic studies concentrate on the characteriza-
tion of members of transmission clusters, individuals on isolated
branches in the phylogenetic tree may even so hold important in-
formation. In our study they were, as expected, more frequently female,
SSA, infected abroad, infected with a non-B subtype and diagnosed with
a longstanding infection. We assume that the majority of these infec-
tions are dead ends with regard to transmission and infections that
could not have been prevented by local prevention initiatives.
However, almost half (47.6%) of the 471 patients on individual bran-
ches with known country of infection reported being infected in
Belgium. Of these locally infected individuals 65.6% of the 215 with
known transmission risk were MSM and 29.0% of the 279 with in-
formation on the infection time were diagnosed early after infection.
This high number of recently infected patients belonging to the most at
risk population and likely infected in Belgium but for whom the in-
fection source was not sampled, was unexpected. Possible explanations
are that the source partners were diagnosed before 2013, are still un-
diagnosed or have not yet entered care. Considering the good con-
tinuum of care in Belgium and the high percentage of patients suc-
cessfully treated (Van Beckhoven et al., 2015) the risk for transmission
from patients diagnosed before 2013 is assumed to be low. The in-
volvement of undiagnosed infections however cannot be excluded.
Using a back calculation model and the HIV surveillance data collected
between 2006 and 2015, the number of individuals living with un-
diagnosed HIV in Belgium was estimated at 2800 (95% CI 2200–3500)
(Marty et al., 2017). From a prevention perspective, it will be important
to further explore the characteristics of individual branched patients,
ideally using phylogenetic data obtained in real time and combined
with information on patients' behavior.
4.7. Limitations
Our study has some limitations. Although we were able to include
the majority of patients for whom a baseline drug resistance analysis
has been performed, the selection comprised only about 60.0% of all
newly diagnosed individuals registered in the national surveillance
database during the study period. An important reason for missing
patients is that all individuals seeking medical care in Belgium and
diagnosed with HIV infection are registered, including those with an
HIV infection already established abroad and those with a history of
antiretroviral therapy. For obvious reasons, the latter are not included
in the baseline drug resistance testing program. Another potential bias
may result from the fact that data on transmission risk or country of
infection are not always available and that the reliability of these data is
diﬃcult to evaluate. We assume however that the number of patients
with trustworthy data is high enough to minimize eventual errors re-
sulting from misreporting.
We used only a small region of the viral genome for phylogenetic
analysis. Hue et al. however, clearly demonstrated the suitability of this
part of the HIV-1 pol region for phylogenetic analysis and
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reconstruction of transmission events (Hue et al., 2004).
Paired patients were not considered as clusters in this study because
it was clear from the comparison between paired and clustered patients
and between paired and individual branched patients that paired pa-
tients represent a heterogeneous group. Although the importance of
pairs as sources of further ongoing transmission is unclear, it is assumed
that a large part of the pairs reﬂect transmission among regular partners
with infection diagnosed as part of partners testing (Lubelchek et al.,
2015). In many phylogenetic studies however, pairs are classiﬁed and
analyzed as transmission clusters and this may introduce bias (Brown
et al., 2009; Yerly et al., 2009; Frange et al., 2012; Hue et al., 2014;
Ragonnet-Cronin et al., 2016).
4.8. Conclusions
In conclusion, this study combined phylogenetic, demographic,
epidemiological and laboratory data to show that local HIV-1 trans-
mission in Belgium remains almost exclusively driven by native MSM
despite the overall heterogeneous composition of the HIV-1 infected
population with regard to patient origin and transmission route.
Participation of SSA in clustered transmission was rare and in majority
also MSM driven. Transmission clusters of mixed patient origin may
constitute opportunities for the cross over of non-B subtypes to the
native MSM population and this is an evolution that needs to be mon-
itored.
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